The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Adiponectin and Coronary Heart Disease: A Prospective Study and Meta-Analysis
Open accessAbstract
Background— There is uncertainty about the association between circulating concentrations of adiponectin and coronary heart disease (CHD) risk. We report new data from a prospective study in the context of a meta-analysis of previously published prospective studies. Methods and Results— We measured baseline adiponectin levels in stored serum samples of 589 men with fatal CHD or nonfatal myocardial infarction and in 1231 controls nested within a prospective study of 5661 men (aged 40 to 59 years) recruited during 1978–1980, as well as in paired samples obtained 4 years apart from 221 of these participants. Baseline adiponectin concentrations correlated ( P <0.0001) positively with HDL cholesterol ( r =0.33) and inversely with C-reactive protein ( r =−0.11) and BMI ( r =−0.21), and the year-to-year consistency of adiponectin values was comparable to those of blood pressure and total cholesterol levels. No significant difference between median adiponectin levels at baseline was observed between cases and controls (10.2 versus 10.8 μg/mL; P =0.5), despite the fact that body mass index, HDL, and C-reactive protein were all significant predictors of events in this cohort. The odds ratio for CHD was 0.89 (95% CI, 0.67 to 1.18) in a comparison of men in the top third of adiponectin concentrations compared with those in the bottom third, similar to a meta-analysis (including the present study) of 7 prospective studies involving a total of 1318 CHD cases (odds ratio, 0.84 [95% CI, 0.70 to 1.01]). Conclusions— In contrast to the strong associations previously reported between adiponectin levels and risk of type 2 diabetes, any association with CHD risk is comparatively moderate and requires further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A. M., & Pajak, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,263
Novel Modulator for Endothelial Adhesion Molecules: Adipocyte-Derived Plasma Protein Adiponectin
Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., et al. (1999) · Circulation · doi:10.1161/01.cir.100.25.2473 · Cited by 2,147
Danesh, J., Collins, R., Appleby, P., & Peto, R. (1998) · JAMA · doi:10.1001/jama.279.18.1477 · Cited by 2,026
Self-citationPlasma Adiponectin Levels and Risk of Myocardial Infarction in Men
Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,773
Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Nishida, M., Takahashi, M., Muraguchi, M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.11.1296 · Cited by 1,737
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692
Self-citationEffects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
Després, J.-P., Golay, A., & Sjöström, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044537 · Cited by 1,392
Adiponectin and protection against type 2 diabetes mellitus
Spranger, J., Kroke, A., Möhlig, M., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12255-6 · Cited by 1,120
Adiponectin and development of type 2 diabetes in the Pima Indian population
Lindsay, R. S., Funahashi, T., Hanson, R. L., Matsuzawa, Y., Tanaka, S., Tataranni, P. A., Knowler, W. C., & Krakoff, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09335-2 · Cited by 1,094
Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis
Yamauchi, T., Kamon, J., Waki, H., Imai, Y., Shimozawa, N., Hioki, K., Uchida, S., Ito, Y., Takakuwa, K., Matsui, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209033200 · Cited by 911
Clarke, R., Shipley, M., Lewington, S., Youngman, L., Collins, R., Marmot, M., & Peto, R. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010013 · Cited by 877
Zoccali, C., Mallamaci, F., Tripepi, G., Benedetto, F. A., Cutrupi, S., Parlongo, S., Malatino, L. S., Bonanno, G., Seminara, G., Rapisarda, F., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131134 · Cited by 761
Havel, P. J. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200202000-00008 · Cited by 575
Physical Activity and Hemostatic and Inflammatory Variables in Elderly Men
Wannamethee, S. G., Lowe, G. D. O., Whincup, P. H., Rumley, A., Walker, M., & Lennon, L. (2002) · Circulation · doi:10.1161/01.cir.0000016346.14762.71 · Cited by 487
Self-citationAdiponectin Multimeric Complexes and the Metabolic Syndrome Trait Cluster
Lara-Castro, C., Luo, N., Wallace, P., Klein, R. L., & Garvey, W. T. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-1105 · Cited by 480
Yang, W.-S., Jeng, C.-Y., Wu, T.-J., Tanaka, S., Funahashi, T., Matsuzawa, Y., Wang, J.-P., Chen, C.-L., Tai, T.-Y., & Chuang, L.-M. (2002) · Diabetes Care · doi:10.2337/diacare.25.2.376 · Cited by 405
Malik, I., Danesh, J., Whincup, P., Bhatia, V., Papacosta, O., Walker, M., Lennon, L., Thomson, A., & Haskard, D. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06104-9 · Cited by 388
Self-citationWang, Y., Xu, A., Knight, C., Xu, L. Y., & Cooper, G. J. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200601200 · Cited by 342
Adiponectin - Its Role in Metabolism and Beyond
Stefan, N., & Stumvoll, M. (2002) · Hormone and Metabolic Research · doi:10.1055/s-2002-34785 · Cited by 292
Adiponectin and its role in the obesity-induced insulin resistance and related complications.
Haluzík, M., Pařízková, J., & Haluzík, M. (2004) · Physiological Research · doi:10.33549/physiolres.930479 · Cited by 247
Renal Pathology in Fabry Disease
Alroy, J., Sabnis, S., & Kopp, J. B. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000016684.07368.75 · Cited by 243
Plasma leptin and prognosis in patients with established coronary atherosclerosis
Wolk, R., Berger, P., Lennon, R. J., Brilakis, E. S., Johnson, B. D., & Somers, V. K. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.050 · Cited by 235
Lawlor, D. A., Davey Smith, G., Ebrahim, S., Thompson, C., & Sattar, N. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0825 · Cited by 219
Self-citationAdiponectin and Coronary Heart Disease: The Strong Heart Study
Lindsay, R. S., Resnick, H. E., Zhu, J., Tun, M. L., Howard, B. V., Zhang, Y., Yeh, J., & Best, L. G. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000153090.21990.8c · Cited by 169
Paradoxical Elevation in Adiponectin Concentrations in Women With Preeclampsia
Ramsay, J. E., Jamieson, N., Greer, I. A., & Sattar, N. (2003) · Hypertension · doi:10.1161/01.hyp.0000095981.92542.f6 · Cited by 167
Self-citationChoi, K. M., Lee, J., Lee, K. W., Seo, J. A., Oh, J.-H., Kim, S. G., Kim, N. H., Choi, D. S., & Baik, S. H. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02063.x · Cited by 163
Adiponectin: Stability in Plasma over 36 Hours and Within-Person Variation over 1 Year
Pischon, T., Hotamışlıgil, G. S., & Rimm, E. B. (2003) · Clinical Chemistry · doi:10.1373/49.4.650 · Cited by 154
Lifestyle and Hemostatic Risk Factors for Ischemic Heart Disease
YARNELL, J. W. G., Sweetnam, P. M., Rumley, A., & Lowe, G. D. O. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.1.271 · Cited by 151
Costacou, T., Zgibor, J. C., Evans, R. W., Otvos, J. D., Lopes-Virella, M. F., Tracy, R. P., & Orchard, T. J. (2004) · Diabetologia · doi:10.1007/s00125-004-1597-y · Cited by 134
A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin
Nakano, Y., Tajima, S., Yoshimi, A., Akiyama, H., Tsushima, M., Tanioka, T., Negoro, T., Tomita, M., & Tobe, T. (2006) · Journal of Lipid Research · doi:10.1194/jlr.d600010-jlr200 · Cited by 133
Twenty year follow-up of a cohort based in general practices in 24 British towns
Walker, M., Shaper, A. G., LENNON, L. T., & Whincup, P. H. (2000) · Journal of Public Health · doi:10.1093/pubmed/22.4.479 · Cited by 90
Self-citationEmberson, J., Whincup, P. H., Morris, R. W., Walker, M., Lowe, G. D. O., & Rumley, A. (2004) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000114967.39211.e5 · Cited by 80
Self-citationAdiponectin Predicts Insulin Resistance But Not Endothelial Function in Young, Healthy Adolescents
Singhal, A., Jamieson, N. B., Fewtrell, M. S., Deanfield, J. E., Lucas, A., & Sattar, N. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0131 · Cited by 42
Self-citationBodary, P. F., & Eitzman, D. T. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000200222.55680.df · Cited by 13
Cited by
Adipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
Pathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583
Adipose tissue dysfunction in obesity, diabetes, and vascular diseases
Hajer, G. R., van Haeften, T. W., & Visseren, F. L. J. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn387 · Cited by 1,410
Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction
Achari, A., & Jain, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061321 · Cited by 1,158
Metadata
- Authors
- Sattar, N., Wannamethee, G., Sarwar, N., Tchernova, J., Cherry, L., Wallace, A. M., Danesh, J., & Whincup, P. H.
- Venue
- Circulation
- Published
- 2006-08-15
- Volume
- 114
- Issue
- 7
- Pages
- 623-629
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2003224969
- Cited by
- 403
- References
- 35
- FWCI
- 23.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.